The FDA has granted Rare Pediatric Disease Designation for the ABO-202 program (AAV-CLN1), an AAV-based gene therapy for the treatment of CLN1 disease (infantile and late infantile onset... read more
The FDA has granted Rare Pediatric Disease Designation for the ABO-202 program (AAV-CLN1), an AAV-based gene therapy for the treatment of CLN1 disease (infantile and late infantile onset... read more
This act, sponsored by Louise Slaughter D-NY, directs the Attorney General to establish a stewardship program to facilitate the collection and disposal of prescription medication. The apparent... read more
The MasSpec Pen has been awarded the SXSW Interactive Innovation Award in the Health, Med and Biotech category. The MasSpec Pen is a handheld device that allows surgeons to identify cancerous... read more
The “Right to Try” bill failed a vote in the House on Tuesday. After being unveiled over the weekend, the bill was rushed to a vote using a procedure normally reserved for uncontroversial bills.... read more
This Tuesday, the House will vote on a revised version of the “Right to Try” Act that gives critically ill patients access to experimental medications.
Last summer... read more